Tottori, Japan

Tasuku Harada

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tasuku Harada: Innovator in Gynecological Therapeutics

Introduction

Tasuku Harada is a notable inventor based in Tottori, Japan. He has made significant contributions to the field of gynecological therapeutics, particularly in addressing estrogen-dependent diseases. His innovative approach has led to the development of a unique therapeutic agent aimed at treating conditions such as endometriosis and uterine fibroids.

Latest Patents

Harada holds a patent for an "Estrogen receptor β partial agonist having estrogen receptor α inhibitory effect, and gynecological disease therapeutic agent using same." This patent addresses the problem of providing a therapeutic agent for estrogen-dependent gynecological diseases. The solution involves using an estrogen receptor α-inhibiting β partial agonist, represented by a specific formula, as an active ingredient in the therapeutic agent. He has 1 patent to his name.

Career Highlights

Throughout his career, Harada has worked with esteemed organizations such as Nobelpharma Co., Ltd. and Tottori University. His work has been instrumental in advancing the understanding and treatment of gynecological diseases, showcasing his dedication to medical innovation.

Collaborations

Harada has collaborated with notable colleagues, including Kenichiro Nakao and Fuminori Taniguchi. These partnerships have further enriched his research and development efforts in the field of gynecological therapeutics.

Conclusion

Tasuku Harada's contributions to gynecological therapeutics highlight his innovative spirit and commitment to improving women's health. His patent for a novel therapeutic agent demonstrates the potential for advancements in treating estrogen-dependent diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…